Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Patupilone and RAD001 in Patients With Refractory Solid Tumor Malignancy

NCT00496600 is registered in ClinicalTrials.gov with University of Medicine and Dentistry of New Jersey as lead sponsor.

NCT NCT00496600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00496600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Patupilone and RAD001 in Patients With Refractory Solid Tumor Malignancy
Lead sponsor
University of Medicine and Dentistry of New Jersey
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2007
Completion date
February 28, 2011
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory malignancy